AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Timing matters when it comes to retirement planning. Learn when you should start planning to maximize your savings and ensure a secure future.
26,056 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Kraken rolls out a Solana token flow that enables 2,500+ on-chain tokens to trade inside the main app, but tokens rem...
Apple warns memory costs may squeeze margins and push pricing for the iPhone 18 cycle. Investors are weighing how you...
HUD launches two tech-enabled pilots designed to increase housing supply and cut costs. The programs target robotics ...
Cumberland, Fluid, and SwissBorg join Hashi ahead of Sui's July testnet launch, expanding Bitcoin-backed DeFi rails a...
XRP faces a volatile road ahead as escrow releases, ETF demand, and broader crypto cycles converge. Analysts weigh se...
TRM Labs identifies CoinEx as the largest exit channel for Iran linked crypto flows, tracing billions since 2019 and ...
June data show a surge in miner deposits to Binance, with inflows eclipsing 150,000 BTC and marking a four-month peak...
Tanger Outlets, a leading retail REIT, reports a rebound in shopper traffic and demand across its outlet centers in e...
Volatility tests reshape the defensive playbook in consumer staples. Coca-Cola edges ahead of PepsiCo on cash flow an...
In 2026, a wave of AI-powered tools is reshaping how agents manage leads, websites, and transactions as the market sh...
Independence Day grilling costs rise to a new peak for a 10-person cookout, underscoring how inflation is shaping hol...